Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.695 USD | +0.54% | +0.22% | +27.47% |
May. 29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
May. 29 | Pulmatrix, Inc. Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.27B | - | |||||
118B | ||||||
106B | ||||||
24.28B | - | |||||
21.96B | - | |||||
18.16B |